<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="59000">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02337920</url>
  </required_header>
  <id_info>
    <org_study_id>TEA-NIRS</org_study_id>
    <nct_id>NCT02337920</nct_id>
  </id_info>
  <brief_title>Prediction of Femoral Revascularization Quality Using the Somatic NIRS Signal</brief_title>
  <acronym>TEA-NIRS</acronym>
  <official_title>Prediction of Femoral Revascularization Quality Using the Somatic NIRS Signal</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Caen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Caen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Despite effective femoral artery endarteriectomy, patients with occlusive arteritis may need
      complementary stenting of revascularization procedures within the 2 years after the primary
      surgery because of a poor blood supply in their lower limb extremity. The Near infrared
      spectrophotometry (NIRS) is a non-invasive monitoring of the brain or tissue oxygenation and
      provide information on the quality of the local oxygen supply. The aim of our observational
      study is to correlate the intraoperative NIRS variations at the calf and the soles and the
      one-year evolution of the arteritis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Anticipated">March 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Relationship between the Maximum NIRS difference before and during the femoral artery clamping and the increase of walking perimeter</measure>
    <time_frame>Change - One month, six months and one year after the surgery</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Lower Limb Vascular Surgery - Femoral Artery Endarteriectomy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing unilateral femoral endarteriectomy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing unilateral femoral endarteriectomy

        Exclusion Criteria:

          -  emergency surgery, allergy to adhesive glues, skin abnormalities of the operated leg,
             multiple associated revascularization procedures other than endarteriectomy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Georges Daccache, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Caen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Georges Daccache, M.D</last_name>
    <phone>+ 33 2 06 47 36</phone>
    <email>daccache-g@chu-caen.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Caen University Hospital</name>
      <address>
        <city>Caen</city>
        <state>Calvados</state>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Georges Daccache, MD</last_name>
      <phone>+ 33 2 31 06 47 36</phone>
      <phone_ext>31</phone_ext>
      <email>daccache-g@chu-caen.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <lastchanged_date>July 30, 2015</lastchanged_date>
  <firstreceived_date>November 27, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
